
Novo Nordisk A/S NVO
$ 39.97
-2.91%
Annual report 2025
added 04-18-2026
Novo Nordisk A/S Cash Conversion Cycle 2011-2026 | NVO
Annual Cash Conversion Cycle Novo Nordisk A/S
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 286 | 279 | 256 | 250 | 233 | 207 | 218 | 247 |
All numbers in DKK currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 286 | 207 | 247 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
Compugen Ltd.
CGEN
|
-82.7 | $ 2.59 | -5.31 % | $ 242 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-400 | $ 0.91 | 3.25 % | $ 6.69 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
257 | $ 22.57 | -0.44 % | $ 3.74 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Evogene Ltd.
EVGN
|
-32.5 | $ 0.78 | -0.66 % | $ 27.9 M | ||
|
Fennec Pharmaceuticals
FENC
|
148 | $ 6.33 | -5.52 % | $ 181 M | ||
|
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Galapagos NV
GLPG
|
67.1 | $ 27.94 | -1.69 % | $ 2.69 B | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
BioDelivery Sciences International
BDSI
|
340 | - | -4.8 % | $ 255 M | ||
|
Innoviva
INVA
|
24.6 | $ 23.2 | -2.08 % | $ 1.56 B | ||
|
Aquestive Therapeutics
AQST
|
-172 | $ 4.06 | -0.73 % | $ 434 M | ||
|
Jaguar Health
JAGX
|
289 | $ 0.23 | -5.44 % | $ 536 K | ||
|
Arcutis Biotherapeutics
ARQT
|
158 | $ 22.63 | -2.86 % | $ 2.88 B | ||
|
KalVista Pharmaceuticals
KALV
|
-816 | $ 26.73 | 38.9 % | $ 1.44 B | ||
|
Autolus Therapeutics plc
AUTL
|
119 | $ 1.42 | -4.39 % | $ 378 M | ||
|
Kamada Ltd.
KMDA
|
163 | $ 8.14 | -0.09 % | $ 260 M | ||
|
AstraZeneca PLC
AZN
|
-58 | - | - | $ 96.9 B |